Marilyn J. Aardema, PhD Joins BioReliance Corporation as Chief Scientific Officer, Toxicology

Published: Nov 15, 2010

ROCKVILLE, Md.--(BUSINESS WIRE)--BioReliance announced today that Marilyn J. Aardema, PhD has been named Chief Scientific Officer, Toxicology, to provide oversight for all scientific and regulatory aspects of the Company’s Toxicology division. She reports to the President and CEO, Charles C. Harwood, Jr.

Back to news